Pro-Flora Women's Probiotic By Integrative Therapeutics Overview & Drug Interactions
Check For Interactions With Pro-Flora Women's Probiotic
Supplement: Pro-Flora Women's Probiotic by Integrative Therapeutics
This product contains
Below is a list of the 'active' ingredients listed on the supplement label for this product.
For a list of 'other ingredients', such as fillers, please see the 'Label Information' section on this page.
Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1
Ingredient Group | Blend (Metabolite, constituent, extract, isolate, or combination of these) |
---|---|
Category | blend |
-
Lactobacillus reuteri, RC-14
Ingredient Group Lactobacillus reuteri Category bacteria
Lactobacillus rhamnosus, GR-1
Ingredient Group Lactobacillus rhamnosus Category bacteria
Drugs that interact with Pro-Flora Women's Probiotic by Integrative Therapeutics
Below is a list of drug interactions for each ingredient in this supplement product. Please note that a supplement product may contain more than one ingredient that has interactions.
There were no interactions found with Pro-Flora Women's Probiotic. This does not mean the potential for an interaction does not exist, however. There is often a lack of studies and data surrounding traditional medicine, especially concerning drug interactions, so it is important to always consult your provider before making any changes to your medication regimen.
Label Information
Supplement Facts:
Daily Value (DV) Target Group(s): | Adults and children 4 or more years of age |
---|---|
Minimum serving Sizes: |
1 Capsule(s)
|
Maximum serving Sizes: |
1 Capsule(s)
|
UPC/BARCODE | 871791706712 |
Ingredient | Amount per Serving | Group | % DV, Adults & children 4+ years |
---|---|---|---|
Lactobacillus reuteri RC-14 and Lactobacillus rhamnosus GR-1 |
30 mg
|
Blend (Metabolite, constituent, extract, isolate, or combination of these) |
--
|
Lactobacillus reuteri, RC-14 |
0 NP
|
Lactobacillus reuteri |
|
Lactobacillus rhamnosus, GR-1 |
0 NP
|
Lactobacillus rhamnosus |
|
Other Ingredients: |
Maltodextrin
Hydroxypropyl Methylcellulose
Cellulose
Magnesium Stearate
Titanium Dioxide
|
---|
Label Statments:
Brand IP Statement(s) |
- 2017
- RC-14 and GR-1 are trademarks of Chr. Hansen A/S.
|
---|---|
General Statements |
- Product of Denmark
- Each capsule contains a minimum of 1 billion CFU through expiration date.
- LBZ70671.A01 BLK7016A
- Potency and viability guaranteed at a minimum of 1 billion CFU through expiration date.
|
General |
- BLK7016A LZ70671.A01
|
Formula |
- Lactobacillus reuteri, RC-14 and Lactobacillus rhamnosus, GR-1
- Contains milk.
|
FDA Statement of Identity |
- Dietary Supplement
|
Precautions |
- Contains milk.
- If taking prescription drugs, consult your healthcare professional prior to use.
|
Suggested/Recommended/Usage/Directions |
- Recommendation: Take 1 capsule daily. May increase to 2 capsules daily as needed, or as recommended by your healthcare professional. May be taken with or without food.
|
Storage |
- Store in a cool, dry location. May refrigerate if desired.
|
Formulation |
- Contains no salt, gluten, soy, artificial flavors or preservatives.
|
FDA Disclaimer Statement |
- This statement has not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.
|
Brand Information
See all products by this brand
Distributed by | |
---|---|
Name | Integrative Therapeutics, LLC |
City | Green Bay |
State | WI |
Country | USA |
ZipCode | 54311 |
Phone Number | 800.931.1709 |
Web Address | integrativepro.com |
Return to the main supplement interaction checker page
Parts of this content are provided by the Therapeutic Research Center, LLC and the Dietary Supplement Label Database.
DISCLAIMER: Currently this does not check for drug-drug interactions. This is not an all-inclusive comprehensive list of potential interactions and is for informational purposes only. Not all interactions are known or well-reported in the scientific literature, and new interactions are continually being reported. Input is needed from a qualified healthcare provider including a pharmacist before starting any therapy. Application of clinical judgment is necessary.
© 2021 Therapeutic Research Center, LLC
Drug descriptions are provided by MedlinePlus.